fda glp-1 warning october 2025 Issues 30 Letters to Telehealth Firms Over Misleading Compounded Marketing GLP-1 prescribing among teens with

ARA290 (also widely referred to as cibinetide or pyroglutamate helixB surface peptide, pHBSP) is a synthetic 11aminoacid peptide engineered from the tissueprotective surface (helix B region) of erythropoietin (EPO)

Cardiovascular Risk Reduction Approval: Several GLP-1s have gained FDA approval for cardiovascular benefits, broadening their clinical utility

Amylin has become a hot mechanism for weight loss drug developers as companies like Novo, Structure, AstraZeneca and Viking Therapeutics chase after approval of their candidates

Retatrutide titration typically begins at the lower end of the dose range and increases gradually over the first 4 to 6 weeks

It should improve the quality of clinician conversations, not replace them